POLE/POLD1 mutation and tumor immunotherapy
Crossref DOI link: https://doi.org/10.1186/s13046-022-02422-1
Published Online: 2022-07-02
Published Print: 2022-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ma, Xiaoting
Dong, Lin
Liu, Xiu
Ou, Kai
Yang, Lin
Text and Data Mining valid from 2022-07-02
Version of Record valid from 2022-07-02
Article History
Received: 6 May 2022
Accepted: 17 June 2022
First Online: 2 July 2022
Declarations
:
: The authors declare that they have no competing interests.
: Not applicable.